LymeNet Flash: How can they do this to these kids???

This is topic How can they do this to these kids??? in forum Medical Questions at LymeNet Flash.

To visit this topic, use this URL:
https://flash.lymenet.org/ubb/ultimatebb.php/topic/1/98530

Posted by Pinelady (Member # 18524) on :

http://www.ncbi.nlm.nih.gov/pubmed/20798949
2010 Aug 28.
Arthritis in children represents a diagnostic and therapeutic challenge.
The diagnostic spectrum is broad and a very precise indication

for
diagnostic and therapeutic procedures, especially in small children, is
important.

In addition to acute arthritides - viral arthritis, reactive
arthritis, Lyme arthritis and septic arthritis - secondary chronic
arthritis related to an underlying disease as well as

juvenile
idiopathic arthritis (JIA), the most common chronic inflammatory
systemic disease in children, need to be considered.

This overview is a
guide to the diagnosis of arthritis in childhood and to evidence-based
therapy of JIA in particular.

This consists of a combination of
nonsteroidal anti-inflammatory drugs, systemic and intraarticular
corticosteroids, traditional DMARDs such as sulfasalazine, methotrexate
and leflunomide, the TNF inhibitors etanercept, adalimumab and, with
restrictions, infliximab, other biopharmaceuticals such as anakinra,
canakinumab and rilonacept, and tocilizumab and finally, abatacept.
--------------------------------------------
How can they diagnose Lyme without giving a challenge and using all the bands,

and instead of treating with long term antibiotics---cover it up with Ice Cream.

IMO there is no such thing as JIA, there are only idiot doctors who refuse to believe the tests can lie.

[ 09-02-2010, 08:39 AM: Message edited by: Pinelady ]

Posted by Lymetoo (Member # 743) on :

It's criminal!

SOOO.....

THESE drugs are better than giving them antibiotics????? [cussing]

"This consists of a combination of
nonsteroidal anti-inflammatory drugs, systemic and intraarticular
corticosteroids, traditional DMARDs such as sulfasalazine, methotrexate
and leflunomide, the TNF inhibitors etanercept, adalimumab and, with
restrictions, infliximab, other biopharmaceuticals such as anakinra,
canakinumab and rilonacept, and tocilizumab and finally, abatacept."

Posted by Pinelady (Member # 18524) on :

Oh dear God-----http://www.uveitissociety.org/pages/diseases/jia.html

In the United States, one in every 1000 children develops JIA.